Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone notice the news today about Merck helping produce the JNJ vaccine. Anyone know what small company has been working on vaccine production techniques with Merck? Oh yeah- Enwave
ENWAVE SIGNS TECHNOLOGY EVALUATION AND LICENSE OPTION AGREEMENT WITH LEADING TURKISH DAIRY COMPANY AND ANNOUNCES EQUITY INCENTIVE GRANT
GlobeNewswire MAR 01, 2021 09:00 AM EST
VANCOUVER, British Columbia, March 01, 2021 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a technology evaluation and license option agreement (the “TELOA”) with Sütas süt ÜrünleriI A.S. (“Sütas”), a leading Turkish dairy company. Sütas will evaluate EnWave’s proprietary Radiant Energy Vacuum (“REV™”) dehydration technology for the dehydration of premium dairy snacks and ingredients.
EnWave will install a 10kW REV™ machine at a site of Sütas’ choosing in Turkey for a period of up to six months for research and development purposes. The TELOA grants Sütas the option to enter into a royalty-bearing commercial license to produce REV™-dried commercial dairy products for both domestic and international sales. REV™ technology is currently being used commercially by more than a dozen dairy companies internationally.
Equity Incentive Grant to Officer
As part of the business transformation plan recently announced at NutraDried, Mr. Dan Henriques, EnWave’s Chief Financial Officer, has been appointed as Chief Operating Officer of NutraDried to oversee the streamlining of operations. In recognition of this appointment, the Company has granted Mr. Henriques an aggregate of 142,000 incentive stock options, subject to the terms of the Company’s Stock Option Plan (the “Plan”), that are exercisable at the last closing price of the Company’s common shares on the TSX Venture Exchange (“TSXV”) on February 26, 2021. The incentive stock options are exercisable for a term of five years expiring on February 26, 2026 and will vest in accordance to the provisions set out in the Plan, or as otherwise required by the TSXV. The Company also granted Mr. Henriques an aggregate of 25,000 Restricted Share Rights (“RSRs”) pursuant to the Company’s Restricted Share Rights Plan. The RSRs granted will vest three years from the date of the award.
Very interesting close
Enwave said f to the color Red!
EnWave to Report First Quarter 2021 Financial Resultson February 26, 2021 and Host Investor Conference Call
One stop shop!!! Wish i owned more shares 12400
Cannabis, fruit and vegetables, cheese, snacks, drugs and biologics, and military rations. The future is ours! All we need is patience.
Yes, after the company said they were buying $10mil shares because these prices are a joke i loaded the boat and got my average down to .77 only 12400 shares but happy with it
Just so many potential catalysts over the next few months. Today it’s a white paper on cannabis. Just keep it coming ENWAVE!!!!!
Get that corona virus vaccine deal we go to $100
What do you think? https://www.enwave.net/pharmaceutical
Agree. I think is one that will uplist at some point. They need to continue to promote their performance.
Merck. The Merck report is actually fantastic news. Enwave will have diversified streams of income and the report confirms the uniqueness of Enwave's technology. We only have to wait for the royalties (many different sources). We can't lose. We need some better PR.
ENW Globe says Linsdell reiterates his "buy" for EnWave - Canada Stockwatch
23-Dec-2020 02:45:26
The Globe and Mail reports in its Wednesday, Dec. 23, edition that Industrial Alliance Securities analyst Neil Linsdell has reiterated his "buy" call on EnWave. The Globe's David Leeder writes in the Eye On Equities column that Mr. Linsdell boosted his share target by a nickel to $1.80. Analysts on average target the shares at $1.56. Mr. Linsdell notes that EnWave posted
better-than-anticipated fourth quarter results. He lauds the company for navigating "a difficult fiscal 2020." The technology company, known for its Radiant Energy Vacuum for the dehydration of organic materials, posted revenue of $10.8-million, down 33 per cent year-over-year but topping the analyst's $9.9-million estimate. Mr. Linsdell says in a note: "The decline was expected in part due to a different promotional program (buy one, get one) with Costco versus last year's coupon program. ... Despite some setbacks/delays in machine sales, and a slow progression with Canadian cannabis partners, we are
expecting an accelerated roll-out of Moon Cheese across multiple retail channels and partners to drive growth in 2021. We also expect the company to use its current $18-million cash balance and NCIB to support the share price if it weakens."
Lees meer op: https://beursig.com/forum/viewtopic.php?f=6&t=1905&p=522049#p522049 voor meer informatie
Yes on their website
RSI is low thank goodness!! Hope for a good press release and monday we can jam
Any word on the earnings any1??
After hours which is never something I am a fan of. They need to stop announcing after hours on a Friday even if the results aren’t great. It’s just not a good look.
Agreed. It’s a natural, organic, slow and grinding rise. No BS.
Enwave is the quite giant!!!!
What i love is there is pumping going on here, just good ol’ news and price action..
$.77 average cheeee lets go $2.20 +
I just keep buying
Some solid marijuana news today. Love these under the radar PRs. No volume? No problem. Who would try to pick the best future marijuana company?? Total crapshoot. But invest in the company that has a patented processing technique which all of the companies are going to be using to improve their product and help mass produce at reasonable costs... now we are talking.
ENWAVE'S TERPENE MAX(TM) REV(TM) DRYING PROCESS SURPASSES INDUSTRY AVERAGES FOR ROOM DRIED CANNABIS
GlobeNewswire DEC 08, 2020 09:00 AM EST
VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- EnWave Corporation ( TSX -V: ENW | FSE : E4U) (“EnWave ,” or the “Company”) announces today the successful research and development results of a new terpene retention process for drying cannabis using Radiant Energy Vacuum (“REV™”) dehydration technology. Third-party, lab-verified results demonstrate that EnWave’s patented REV™ technology can deliver a higher percentage of retained terpenes, approximately 10% higher, than traditional cannabis drying methods such as air drying or rack/room drying. The Company offers scaleable, continuous REV™ machinery that can process up to 28 metric tons of high-terpene, dried cannabis per year using the Terpene Max™ process, and up to 46 metric tons of dried cannabis to be used for extraction purposes per year.
This new process, branded as Terpene Max™, further demonstrates the advantages of the Company’s scaleable, proprietary vacuum-microwave drying technology for the global cannabis industry. Terpene Max™ ensures that drying temperatures remain well below 40 degrees Celsius for the entire drying process, which takes less than two hours.
The chart accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e0f4eb4-c3f4-4f77-b798-a234a3f713cc
Chart: The data in the chart above was analyzed at an independent testing facility. The results shown represent the average percentage of terpenes retained from three separately analyzed samples of the same batch of dried cannabis.
The initial quan titati ve results from using the new Terpene Max ™ drying program on a specific low-THC cannabis strain demonstrated an average terpene retention level of 8 8 percent when compared to the fresh flower , making it materially superior to traditional air or rack /room drying where terpene retention average s 79 percent.
The tests were conducted for the Company by accredited, third-party testing facilities using cannabis product dried with large-scale, continuous REV™ technology at a licensed partner’s facilities against standard room-dried protocols. Further data, analysis and certified results will be released in a white paper that will be published in January 2021.
Terpenes are known to have therapeutic effects and are foundational to aromatherapies. Industry research shows that terpenes from cannabis work synergistically with cannabinoids to deliver a better user experience.
EnWave believes that the Terpene Max™ process has the potential to create an ultra-premium consumer product. The Company will be executing further trials with multiple cannabis strains in the coming months to understand the full potential of Terpene Max™ on ultra-premium combustible flowers.
Since obtaining Health Canada’s approval for its independent cannabis research and development lab, EnWave has used this opportunity to expand research and to develop programs such as Terpene Max™. With a fully commissioned R&D facility, the Company is now available to perform cannabis testing and demonstrations for prospective partners evaluating the use of REV™ technology to process cannabis.
With EnWave now able to conduct on-site trials with various cannabis strains, the perceived technology risk is reduced for prospective licensees.
REV™ drying technology provides cannabis producers with a rapid and gentle drying solution that produces premium cannabis products for both extraction and combustion while significantly reducing processing delays. The REV™ process can also reduce the bioburden in the product and lowers the risk of crop loss due to microbes and other quality issues. REV™ has been embraced by several licensed cannabis and hemp producers in Canada, Switzerland, New Zealand, Australia, and the United States of America.
This is old, surely was posted before and is probably known to most on this board. But for anyone who wants a good summary of EnWave's operation and a good forecast of its potential, this is a must read.
https://smallcaps.us/reports/CR_ENW.pdf Apologies to those who have already seen this. To my mind, it is so convincing. I just keep buying more. I may be preaching to the choir.
Someone like this could also get involved
.https://ovens.lewcoinc.com/
Dont forget Pepsico...
Waiting for the one big PR
Love all the food PRs. They truly are amazing. And hopefully earnings soon will be decent. But one day soon we will get the big PR- will it be inhaler treatment for COVID, vaccine use with big pharma, army news, marijuana news... Everyone on this board knows it will happen.
I agree. What am I missing here? Seems like it’s trading at a pretty big discount to future rev. No one knows about this stock. The Nippon deal is a big one.
ENWAVE SIGNS ROYALTY-BEARING COMMERCIAL LICENSE AGREEMENT AND EQUIPMENT PURCHASE AGREEMENT WITH NIPPON TRENDS FOOD SERVICES, INC.
GlobeNewswire DEC 01, 2020 09:00 AM EST
VANCOUVER, British Columbia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today that it has signed a Royalty-Bearing Commercial License Agreement (the “License”) and Equipment Purchase Agreement (the “Purchase Agreement”) with Nippon Trends Food Services, Inc. (“Nippon”), a California-based company with operations in Canada and the U.S. that manufactures premium ramen noodles under its Yamachan Ramen brand. During an in-depth evaluation of EnWave’s patented Radiant Energy Vacuum (“REV™”) dehydration technology, Nippon and the Company successfully developed a process to dehydrate fresh ramen noodles that rehydrate back to a fresh quality. Nippon intend to commercialize this application under the License.
EnWave’s REV™ dehydration technology has been chosen for many product applications where rehydration is a key determining factor. Ramen noodles are a globally consumed product and the estimated global market for the product was USD$44 billion in 2019 and is projected to reach USD $72 billion by 2027. EnWave will continue to seek additional opportunities in the broad marketplace where premium re-hydrated products benefit from a REV™ drying treatment.
Nippon has also signed the Purchase Agreement for a 10kW REV™ machine to be installed in Canada to initiate commercial production. The License granted by the Company to Nippon is exclusive for the processing of ramen noodles in Canada, and Nippon is required to purchase a large-scale REV™ machine with a minimum of 100kW of rated power within twelve months from the commissioning of the first 10kW REV™ machine in order to retain the exclusivity granted under the License.
EnWave’s scalable and reliable vacuum-microwave technology can be used to significantly reduce the drying time for freshly produced ramen noodles while allowing for texture and flavour preservation in the rehydrated product. This presents a major innovation opportunity for Nippon to reduce processing costs and increase plant throughputs of their retail ramen products. It also allows Nippon to produce a more premium portfolio of products in an economical fashion. This License is the first granting the right to manufacture noodles using REV™ technology and the Company believes there is significant global potential for the commercialization of this process in the Asia Pacific region.
About Nippon
Nippon is a family-owned company, established by Hideyuki Yamashita in 2000, that utilizes advanced machinery technology and high quality ingredients to manufacture its premium Yamachan noodle brand. Headquartered in San Jose, California with additional production capacity in Vancouver, Nippon has proudly manufactured its Japanese ramen noodles, udon, and Japanese-style gyoza for 20 years.
About EnWave
EnWave Corporation, a Vancouver-based advanced technology company, has developed a Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to high-quality, marketable cannabis products.
REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors, including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with innovative, disruptive companies in multiple verticals for the use of REV™ technology. The company has signed over forty royalty-bearing licenses to date in twenty countries world-wide. In addition to these licenses, EnWave established a Limited Liability Corporation, NutraDried Food Company, LLC, to manufacture, market and sell all-natural dairy snack products in the United States, including the Moon Cheese ® brand.
EnWave has introduced REV™ as a disruptive dehydration platform in the food and cannabis sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently offers two distinct commercial REV™ platforms:
Its gotta come soon. I am being patient.
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave” or, the "Company") announced today that it has signed its second Equipment Purchase Agreement with Patatas Fritas Torres S.L. (“Patatas Torres”), a leading snack manufacturer in Spain. This purchase is for a much larger 100kW Radiant Energy Vacuum (“REV™”) machine complimenting Patatas Torres’ previous purchase of a 10kW REV™ machine. Patatas Torres signed a commercial royalty-bearing license with EnWave in March 2020 for the right to produce REV™-dried cheese snacks in Spain. The acquisition of this larger continuous vacuum microwave processing line will allow Patatas Torres to meaningfully grow and leverage their successful development and launch of their portfolio of premium cheese snacks under the brand “Just This!” domestically.
Historically a leading manufacturer of premium potato chip products with robust international and domestic distribution, Patatas Torres has committed to diversifying its portfolio to include several healthy snack offerings through this meaningful investment in REV™ technology. Their plan is to develop multiple flavors and formats that appeal to varying international markets and which can be exported through Patatas Torres’ existing distribution network. The planned delivery and start-up of the 100kW REV™ machinery is targeted for May 2021.
About Patatas Fritas Torres S.L.
Patatas Fritas Torres is a Catalonian family business, known for its innovative and entrepreneurial approach to the development and marketing of premium snacks. Patatas Fritas Torres is committed to creating high-quality products that are healthy and tasty, high in nutritional value and that have health benefits for consumers.
Patatas Fritas Torres has received the XXI International Food and Beverage Trophy in Paris and also the XXVII International Trophy for Quality.
Lees meer op: https://beursig.com/forum/viewtopic.php?f=6&start=900&t=1905&sid=849ed8408e8da01d6a173cdeda82ca4b voor meer informatie
Followers
|
9
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
658
|
Created
|
10/18/08
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |